# Australia Virtual Visits Market Size, Share & Forecast, By Service Type, Care Setting & End User, 2025-2032 --- ## Market Overview # CHAPTER 1 - Market Overview The Australia Virtual Visits Market operates through Medicare-funded consultations, private-pay virtual clinics, insurer-supported services and telehealth embedded within existing medical practices. Demand has normalized from pandemic peaks but remains structurally significant: **22.5% of Australians aged 15 years and over used telehealth in 2024-25**, and 90.3% of previous users said they would use it again if offered. Demand is concentrated in Australia's eastern population corridor, where New South Wales, Victoria and Queensland collectively accounted for approximately **77% of the national population in June 2025**. Their scale, clinician density and digitally enabled metropolitan healthcare networks make them the largest virtual-visit demand pools, while remote geography creates an additional access rationale across regional Australia. Regulation increasingly treats virtual consultations as permanent healthcare infrastructure rather than a temporary access mechanism. Ongoing Medicare Benefits Schedule telehealth arrangements are nationally available, while **18 new video and 5 new telephone attendance items became available from July 2025** across specialties including pain, palliative, addiction, sexual health, occupational medicine and gynaecology. The strategic direction is toward an integrated digital-care stack linking virtual consultation, electronic prescribing, referral workflows and longitudinal health records. By April 2024, Australia had issued more than **219 million electronic prescriptions through around 86,000 GP and nurse-practitioner prescribers**. This infrastructure lowers post-consultation friction and improves the commercial viability of virtual-first and hybrid-care pathways. ## KPIs at a Glance * Market Value: USD 1,570 Mn (2025) * Dominant Region: Eastern Australia - New South Wales, Victoria and Queensland (2025) * Dominant Segment: General Practitioner Consultations (fastest growing) * Total Number of Players: 250+ ## Future Outlook The Australia Virtual Visits Market is projected to expand from **USD 1,570 Mn in 2025** to **USD 2,907 Mn by 2032**, representing a forecast CAGR of **9.20%**. The forecast represents a transition from pandemic-led volume expansion to recurring, embedded digital care. Value growth is expected to exceed consultation-volume growth because virtual visits are moving toward specialist, mental-health, chronic-care and insurer-sponsored pathways with higher average revenue per encounter. The model assumes that Medicare retains virtual attendance pathways, private virtual clinics remain clinically compliant, and digital infrastructure continues integrating prescribing, referral and patient-record workflows. Historical performance reflects substantial volatility: the modeled **2020-2025 CAGR is 5.88%**, despite a major 2021 demand spike followed by normalization through 2024. From 2026 onward, growth is expected to become structurally steadier as telehealth penetrates higher-value specialties and hybrid models. Medicare permanence, patient willingness to reuse telehealth, access constraints in physical primary care and investment by health insurers and digital clinics support the base case. The principal downside risks are tighter clinical-governance requirements, commoditization of low-complexity GP consultations and patient-acquisition costs. Upside comes from integrated mental health, after-hours care and chronic-condition follow-up. --- | | | | --- | --- | | **9.20%** Forecast CAGR (2025-2032) | **$2,907 Mn** 2032 Projection | --- | | | | | | --- | --- | --- | --- | | Base Year **2025** | Historical Period **2020-2025** | Forecast Period **2025-2032** | Historical CAGR **5.88%** | --- ## Scope of the Report # CHAPTER 2 - Scope of the Market * **Geographic Coverage:** Australia * **Historical Period:** 2020-2025 * **Base Year:** 2025 * **Forecast Period:** 2025-2032 (base year inclusive) * **Market Segments Covered:** 7 primary segmentation dimensions (Service Type, Care Setting, End User, Clinical Specialty, Distribution Channel, Technology, Geography) * **Companies Covered:** Top 10 key players profiled * **Currency & Units:** USD, values expressed in USD Mn/Bn ### Segmentation Data Tree * Service Type + General Practitioner Consultations - Routine consultations - Prescription and referral consultations + Specialist Consultations - Initial specialist reviews - Follow-up specialist reviews + Mental Health and Allied Health Consultations - Psychology and psychiatry - Allied health consultations + Urgent and After-Hours Virtual Care - After-hours primary care - Acute triage consultations * Care Setting + Primary Care Practices - Independent GP practices - Multi-site medical groups + Specialist and Allied Health Clinics - Specialist medical clinics - Allied health networks + Hospital and Virtual Hospital Services - Hospital outpatient care - Hospital-in-the-home pathways + Direct-to-Consumer Digital Clinics - Virtual-first clinics - Condition-specific digital clinics * End User + Adults Aged 18-64 - Working-age consumers - Young adult consumers + Older Adults Aged 65+ - Independent older patients - Supported-care patients + Children and Adolescents - Paediatric primary care - Family-managed virtual care + Rural and Remote Patients - Regional communities - Remote communities * Clinical Specialty + General Medicine - Acute primary care - Routine follow-up + Mental Health - Psychology - Psychiatry + Women's and Sexual Health - Women's health consultations - Sexual health consultations + Emergency and Acute Triage - Emergency specialist advice - Urgent-care triage * Distribution Channel + Scheduled Practice Telehealth - Practice-booked telephone - Practice-booked video + On-Demand Digital Clinics - Immediate GP access - Condition-specific virtual care + Health Plan and Employer Channels - Insurer-funded care - Employer-sponsored care + Government and Hospital Channels - Public virtual-care programs - Hospital-linked telehealth * Technology + Audio Consultation - Standard telephone consultation - Integrated voice consultation + Video Consultation - Browser-based video - App-based video + Integrated Digital Workflow - Electronic prescribing integration - Referral and payment integration + AI-Assisted Virtual Care - Clinical intake support - Documentation and triage support * Geography + New South Wales - Sydney metropolitan - Regional New South Wales + Victoria - Melbourne metropolitan - Regional Victoria + Queensland - South East Queensland - Regional and remote Queensland + Western and Southern Australia - Western Australia - South Australia, Tasmania and Territories --- ## Market Trajectory # CHAPTER 3 - Market Size, Growth Forecast and Trends This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. | Year | Market Size (USD Mn) | | --- | --- | | 2020 | 1,180 | | 2021 | 2,150 | | 2022 | 1,950 | | 2023 | 1,700 | | 2024 | 1,540 | | 2025 | 1,570 | | 2026F | 1,714 | | 2027F | 1,872 | | 2028F | 2,044 | | 2029F | 2,232 | | 2030F | 2,438 | | 2031F | 2,662 | | 2032F | 2,907 | | Year | YoY Growth Rate (%) | | --- | --- | | 2021 | 82.2% | | 2022 | -9.3% | | 2023 | -12.8% | | 2024 | -9.4% | | 2025 | 1.9% | | 2026F | 9.2% | | 2027F | 9.2% | | 2028F | 9.2% | | 2029F | 9.2% | | 2030F | 9.2% | | 2031F | 9.2% | | 2032F | 9.2% | | Year | Market Value Growth (%) | Virtual Visit Volume Growth (%) | Implied Revenue per Visit (USD) | | --- | --- | --- | --- | | 2020 | - | - | 35.8 | | 2021 | 82.2% | 72.7% | 37.7 | | 2022 | -9.3% | -21.1% | 43.3 | | 2023 | -12.8% | -17.8% | 45.9 | | 2024 | -9.4% | -16.2% | 49.7 | | 2025 | 1.9% | 3.2% | 49.1 | | 2026 | 9.2% | 6.2% | 50.4 | | 2027 | 9.2% | 6.8% | 51.6 | | 2028 | 9.2% | 6.9% | 52.7 | | 2029 | 9.2% | 7.0% | 53.8 | | 2030 | 9.2% | 6.7% | 55.0 | | 2031 | 9.2% | 6.5% | 56.4 | | 2032 | 9.2% | 6.1% | 58.0 | ### Historical Market Performance (2020-2025) The historical curve reflects an exceptional pandemic-driven expansion followed by normalization. Modeled virtual consultation volume increased from approximately 33.0 million visits in 2020 to 57.0 million in 2021, before declining as in-person care resumed. Government data corroborate the scale of this transition: more than 100 million telehealth services were delivered to around 17 million Australians between March 2020 and March 2022. The market stabilized during 2024-2025 as permanent Medicare arrangements, virtual-first providers and hybrid practice models replaced emergency-policy demand. The 2025 confidence band is assessed at approximately USD 1,380-1,760 Mn, implying a model uncertainty of roughly plus or minus 12%. ### Forecast Market Outlook (2025-2032) Forecast growth is expected to be less volume-driven and more dependent on higher-value service mix. Virtual visit volume is modeled to rise from 32.0 million encounters in 2025 to approximately 50.1 million by 2032, a volume CAGR near 6.6%, while implied revenue per encounter rises by roughly 2.4% annually as mental health, specialist, urgent-care and integrated care pathways gain weight. The base scenario reaches USD 2,907 Mn in 2032; a constrained case is approximately USD 2,550 Mn, while stronger insurer adoption and specialty migration could lift the market toward USD 3,300 Mn. Permanent national telehealth billing arrangements materially reduce reimbursement-policy downside. --- ## Market Breakdown # CHAPTER 4 - Market Breakdown The Australia Virtual Visits Market is entering a more stable post-pandemic phase in which visit frequency, patient penetration and monetization per encounter become more informative than emergency-era adoption alone. These operating KPIs indicate where value creation can outpace underlying consultation growth. | Year | Market Size (USD Mn) | YoY Growth (%) | Virtual Visits Volume (Mn) | Telehealth User Penetration (%) | Implied Revenue per Visit (USD) | Period | | --- | --- | --- | --- | --- | --- | --- | | 2020 | 1,180 | - | 33.0 | - | 35.8 | Historical | | 2021 | 2,150 | 82.2% | 57.0 | 30.8% | 37.7 | Historical | | 2022 | 1,950 | -9.3% | 45.0 | - | 43.3 | Historical | | 2023 | 1,700 | -12.8% | 37.0 | - | 45.9 | Historical | | 2024 | 1,540 | -9.4% | 31.0 | 23.6% | 49.7 | Historical | | 2025 | 1,570 | 1.9% | 32.0 | 22.5% | 49.1 | Base Year | | 2026 | 1,714 | 9.2% | 34.0 | 23.0% | 50.4 | Forecast and Latest Operating KPIs | | 2027 | 1,872 | 9.2% | 36.3 | 24.0% | 51.6 | Forecast and Industry Outlook | | 2028 | 2,044 | 9.2% | 38.8 | 25.0% | 52.7 | Forecast and Industry Outlook | | 2029 | 2,232 | 9.2% | 41.5 | 26.0% | 53.8 | Forecast and Industry Outlook | | 2030 | 2,438 | 9.2% | 44.3 | 27.0% | 55.0 | Forecast and Industry Outlook | | 2031 | 2,662 | 9.2% | 47.2 | 29.0% | 56.4 | Forecast and Industry Outlook | | 2032 | 2,907 | 9.2% | 50.1 | 31.0% | 58.0 | Forecast and Industry Outlook | **KPI 1, Virtual Visits Volume:** **32.0 million visits, 2025, Australia**. Scale remains well below the pandemic peak, creating capacity for normalized expansion without requiring lockdown-style adoption. More than 100 million services had already been delivered to 17 million Australians by March 2022. **KPI 2, Telehealth User Penetration:** **22.5%, 2024-25, Australia**. Penetration has stabilized below pandemic highs, but user retention remains strong: 90.3% of people who had used telehealth said they would use it again if offered. **KPI 3, Implied Revenue per Visit:** **USD 49.1, 2025, Australia**. Future monetization is expected to benefit from richer service mix rather than simple price inflation. The MBS added 18 video and 5 telephone attendance items from July 2025 across multiple specialties. --- --- ## Market Segmentation # CHAPTER 5 - Market Segmentation Framework Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns. | | | | | --- | --- | --- | | **No of Segments:** 7 | **Dominant Segment:** Service Type | **Fastest Growing Segment:** Technology | ### Segmentation Framework | Priority | Level-1 Segment / Taxonomy Dimension | Level-2 Sub-Segments | | --- | --- | --- | | 1 | Service Type | General Practitioner Consultations; Specialist Consultations; Mental Health and Allied Health Consultations; Urgent and After-Hours Virtual Care | | 2 | Care Setting | Primary Care Practices; Specialist and Allied Health Clinics; Hospital and Virtual Hospital Services; Direct-to-Consumer Digital Clinics | | 3 | End User | Adults Aged 18-64; Older Adults Aged 65+; Children and Adolescents; Rural and Remote Patients | | 4 | Clinical Specialty | General Medicine; Mental Health; Women's and Sexual Health; Emergency and Acute Triage | | 5 | Distribution Channel | Scheduled Practice Telehealth; On-Demand Digital Clinics; Health Plan and Employer Channels; Government and Hospital Channels | | 6 | Technology | Audio Consultation; Video Consultation; Integrated Digital Workflow; AI-Assisted Virtual Care | | 7 | Geography | New South Wales; Victoria; Queensland; Western and Southern Australia | ### Key Segmentation Takeaways Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns. **Service Type** - General practitioner consultations remain the core revenue and volume engine because primary care generates the highest frequency of healthcare encounters and telehealth is already embedded in MBS workflows. Specialist, mental-health and after-hours services create more attractive revenue-per-visit economics, but general medical consultations continue to provide the installed patient base from which providers can cross-sell higher-value digital-care pathways. **Technology** - Technology is the fastest-evolving dimension as the market shifts from stand-alone telephone consultations toward video, electronic prescribing, integrated referrals, structured digital intake and clinician-supervised AI assistance. Competitive advantage increasingly depends on reducing administrative cost per encounter while preserving clinical governance, identity verification, privacy, continuity of care and interoperability with established Australian healthcare information infrastructure. --- ## Regional Analysis # CHAPTER 6 - Regional Analysis Australia ranks among the largest digitally mature virtual-visit markets in its peer group, supported by permanent national Medicare telehealth arrangements, high patient reuse intent and a large primary-care base. Its penetration has normalized from pandemic peaks, creating a more sustainable comparison with Canada, the United Kingdom, Singapore and New Zealand. ### KPI Summary * Focus Country Ranking: **3rd** * Focus Country Market Size: **USD 1,570 Mn** * Focus Country CAGR (2025-2032): **9.2%** | Country | Market Size, 2025 | CAGR (%) | Estimated Virtual Visits (Mn) | Public Virtual Care Policy / Access Framework | | --- | --- | --- | --- | --- | | Australia | USD 1,570 Mn | 9.2% | 32.0 | Permanent nationally available MBS telehealth | | Canada | USD 2,400 Mn | 8.7% | 45.0 | Provincial virtual-care reimbursement frameworks | | United Kingdom | USD 2,850 Mn | 8.0% | 78.0 | NHS digital and online primary-care access | | Singapore | USD 420 Mn | 11.3% | 7.5 | Licensed telemedicine under national healthcare regulation | | New Zealand | USD 300 Mn | 10.5% | 6.5 | National 24/7 digital primary-care access model | ### Market Position Australia ranks third in the selected peer set at USD 1,570 Mn, supported by a 27.6 million population and 22.5% annual telehealth-user penetration among people aged 15 and over. ### Growth Advantage Australia's modeled 9.2% CAGR exceeds Canada at 8.7% and the United Kingdom at 8.0%, with permanent Medicare coverage and 23 additional attendance items reinforcing specialty expansion. ### Competitive Strengths Australia combines 90.3% telehealth reuse intent, mature e-prescribing infrastructure and scalable public video capability; Healthdirect alone recorded 164,588 Video Call consultations in March 2026. Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. --- ## Growth Drivers # CHAPTER 7 - Growth Drivers, Challenges & Opportunities Comprehensive analysis of key factors shaping the Australia Virtual Visits Market, including growth catalysts, operational challenges, and emerging opportunities across clinical delivery, digital distribution and patient-access segments. ## Growth Drivers ### Permanent Medicare Reimbursement Infrastructure Virtual care has shifted into mainstream reimbursement, with **23 additional telehealth attendance items (2025, Australia)** expanding reimbursable specialty pathways. * Ongoing Medicare telehealth arrangements are nationally available, turning a pandemic mechanism into a structural care channel and reducing reimbursement uncertainty for practices investing in digital workflows. **National ongoing coverage (2026, Australia)** materially supports provider participation. * Australia demonstrated large-scale clinician adoption early: **more than 100 million services to around 17 million patients (March 2020-March 2022, Australia)**, establishing trained providers and patient familiarity that lowers incremental adoption costs. * MBS video and telephone items remain available to GPs, specialists, consultant physicians, nurse practitioners, midwives and eligible allied-health providers, expanding the addressable provider base across **multiple practitioner categories (2026, Australia)**. ### High Patient Acceptance and Persistent Access Gaps Virtual visits retain durable consumer acceptance, with **90.3% reuse intent (2024-25, Australia)** among people who previously used telehealth. * **22.5% of people aged 15+ used telehealth (2024-25, Australia)**, confirming a substantial recurring user base even after emergency pandemic conditions had disappeared. * **26.6% of people delayed or did not see a GP when needed (2024-25, Australia)**, creating a clear access gap that after-hours and on-demand virtual providers can address. * Telehealth use was structurally higher among patients with chronic needs: **31.2% of people with long-term conditions used telehealth versus 13.3% without (2024-25, Australia)**, supporting recurring care pathways. ### Digital Health Infrastructure Integration Australia's virtual-care stack benefits from **more than 219 million electronic prescriptions issued by April 2024**, enabling low-friction digital care completion. * Approximately **86,000 GP and nurse-practitioner prescribers (April 2024, Australia)** had participated in electronic prescribing, materially widening the clinician base capable of completing virtual workflows digitally. * Healthdirect Video Call recorded **164,588 consultations in March 2026 (Australia)**, exceeding its prior monthly record and demonstrating that public digital infrastructure can grow outside pandemic conditions. * MyMedicare supports extended telehealth consultations through a patient's nominated practice and GP, strengthening continuity-led virtual care for **registered MyMedicare patients (2025-26, Australia)**. --- ## Market Challenges ### Post-Pandemic Utilization Normalization Telehealth penetration declined from its emergency peak, falling from **30.8% in 2021-22 to 22.5% in 2024-25**. * Penetration declined from **23.6% in 2023-24 to 22.5% in 2024-25 (Australia)**, demonstrating that operators cannot rely on simple market-wide adoption growth to sustain revenue. * GP service attendance patterns also normalized after COVID-era peaks, with **614.8 GP services per 100 people in 2024-25 (Australia)**, reinforcing the need to compete within established care demand rather than assume incremental healthcare utilization. * Providers must shift from one-off convenience transactions toward recurring clinical pathways because **83.8% of Australians had at least one Medicare-subsidised GP attendance in 2024-25**, preserving strong incumbent practice relationships. ### Clinical Governance and Prescribing Constraints Regulatory scrutiny is increasing, with **updated national telehealth guidance effective in 2025** emphasizing safe prescribing and clinically appropriate consultation models. * AHPRA's updated guidance highlights concerns with models relying principally on text, email or questionnaire-based prescribing, raising compliance costs for **high-volume virtual prescribing models (2025, Australia)**. * Practitioners must determine whether virtual care is clinically appropriate, meaning **100% digital completion is not suitable for every clinical presentation (2025, Australia)**; operators need escalation and physical-care referral pathways. * Medicare telehealth services must meet the clinical requirements of corresponding face-to-face items, making **clinical equivalence requirements (2025-26, Australia)** an operational constraint on ultra-short, automated or low-touch consultation models. ### Digital and Socioeconomic Access Inequality Telehealth adoption remains uneven, with usage of **19.3% in the most disadvantaged areas versus 24.2% in the least disadvantaged areas (2024-25, Australia)**. * Lower adoption among disadvantaged users can reduce the addressable private-pay pool, despite those cohorts often experiencing greater physical-care access constraints. The penetration gap was **4.9 percentage points (2024-25, Australia)**. * **30.7% of people with long-term health conditions delayed or did not use a GP when needed (2024-25, Australia)**, indicating that virtual availability alone does not eliminate affordability, continuity and capacity barriers. * Primary-care data remain nationally incomplete, and AIHW explicitly identifies primary healthcare data as an information gap, creating **ongoing national data-standardisation work (2026, Australia)** that complicates precise provider-level market measurement. --- ## Market Opportunities ### Virtual Mental Health Expansion Mental health is structurally suited to virtual delivery: **26.0% of mental-health service users used telehealth at least once in 2024-25**. * Monetizable demand remains substantial because **34.4% of people needing mental-health care delayed or did not see a professional when needed (2024-25, Australia)**, supporting psychology, psychiatry and hybrid subscription pathways. * Specialist virtual-care providers and insurers benefit most where access bottlenecks are acute: **38.8% of people needing a psychologist delayed or did not see one (2024-25, Australia)**. * Affordability remains the commercialization constraint, with **25.3% of people needing psychologists reporting cost-related delay or non-use (2024-25, Australia)**; successful models require Medicare, insurer or employer funding alongside private-pay options. ### After-Hours and Regional Access Virtual pathways can monetize access friction, illustrated by **164,588 Healthdirect Video Call consultations in March 2026**, the platform's highest recorded monthly volume. * Virtual pathways following Healthdirect triage increased from approximately **15% to a peak of 20% in metropolitan triages during 2026**, showing demand sensitivity to convenience and travel cost. * Regional and remote patients benefit disproportionately from avoided travel, while Healthdirect estimated potentially eligible video substitution could save **more than 34 million litres of fuel annually (2026, Australia)**. * Providers must maintain escalation into physical services because virtual care complements rather than replaces examination-based care; Australia had **200.3 million Medicare-subsidised non-hospital primary-care services in 2024-25**. ### Insurer and Consumer Virtual-Care Bundles Private channels have a large addressable base because **60.3% of Australians aged 15+ reported private health insurance in 2024-25**. * Health insurers can bundle virtual GP, psychology and chronic-care services to improve member engagement while shifting selected low-acuity care away from higher-cost settings; private insurance penetration increased from **59.0% to 60.3% between 2023-24 and 2024-25**. * Direct-to-consumer digital clinics can capture differentiated specialty demand: Eucalyptus reported **more than 700,000 consultations delivered without relying on Medicare rebates**, demonstrating willingness to pay for digitally enabled care programs. * Distribution partnerships can reduce acquisition costs. Healthengine reported links with **more than 10,000 practices and nearly 30,000 practitioners in 2025**, creating a large potential referral and booking infrastructure for hybrid virtual care. --- --- ## Competitive Landscape # CHAPTER 8 - Competitive Landscape Overview The market combines incumbent healthcare groups, large patient-engagement platforms and virtual-first operators. Competition is fragmented, while clinical governance, practitioner supply, patient acquisition, referral integration and trusted payer relationships create meaningful barriers to sustained scale. * **Key players:** 10 * **New Entrants (last 5 yrs):** - ### Company Profiles (Top 10 Players) | Company Name | Market Share | Headquarters | Founding Year | Core Market Focus | | --- | --- | --- | --- | --- | | Medibank / Amplar Health | - | Melbourne, Australia | 1976 | Insurer-integrated virtual health, psychology and healthcare delivery | | Eucalyptus | - | Sydney, Australia | 2019 | Condition-specific virtual clinics and longitudinal digital healthcare | | Healthengine | - | Perth, Australia | 2006 | Patient marketplace, telehealth access and appointment distribution | | HotDoc | - | - | 2012 | Patient engagement, bookings and on-demand telehealth access | | Instant Consult | - | Brisbane, Australia | 2018 | On-demand video consultations with Australian registered doctors | | GP2U Telehealth | - | - | 2011 | Online GP, specialist, prescription and referral consultations | | My Emergency Doctor | - | - | 2016 | Emergency specialist telemedicine and institutional virtual care | | Medmate | - | - | 2018 | On-demand doctor consultations, prescriptions and digital care | | Hola Health | - | Perth, Australia | 2020 | 24/7 virtual GP and on-demand healthcare services | | Updoc | - | - | - | Consumer telehealth consultations, prescriptions and medical documentation | The report provides detailed cross-comparison of key players across 4 performance parameters to identify competitive strengths and weaknesses. ### Top 4 Cross-Comparison KPIs * Virtual Consultation Volume * Clinician Network Capacity * Virtual Care Revenue Growth * Contribution Margin per Consultation ### Analysis Covered * **Market Share Analysis:** Benchmarks provider concentration using in-scope virtual consultation revenue estimates annually. * **Cross Comparison Matrix:** Compares visit volume, clinician capacity, growth and unit economics consistently. * **SWOT Analysis:** Assesses strategic strengths, weaknesses, opportunities and regulatory exposure by provider. * **Pricing Strategy Analysis:** Reviews private-pay, insurer-funded, Medicare-linked and subscription pricing approaches across providers. * **Company Profiles:** Profiles service scope, clinical model, reach, ownership and operating focus. --- --- ## Key Stakeholders # CHAPTER 10 - Key Target Audience Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning. * **Investors:** CAGR, patient acquisition, contribution margin, regulatory exposure, scalability * **Corporates:** employee access, absenteeism, care utilization, integration, procurement economics * **Government:** access equity, Medicare utilization, safety, interoperability, rural coverage * **Operators:** consultation volume, clinician utilization, wait times, retention, compliance * **Financial institutions:** recurring revenue, unit economics, funding needs, consolidation potential ### What You'll Gain * Market sizing and trajectory * Policy and compliance mapping * Virtual-care operating indicators * Segment structure and levers * Competitive landscape shortlist * CEO-grade risk priorities --- --- ## Research Methodology # CHAPTER 11 - Research Methodology ### Phase 1: Approach #### Desk Research * Review Medicare telehealth billing arrangements * Analyze national patient experience statistics * Map virtual consultation provider universe * Benchmark digital-care pricing and volumes #### Primary Research * Interview virtual-care medical directors * Interview telehealth operations managers * Interview general practice owners * Interview health insurer strategy leaders #### Validation and Triangulation * Validate assumptions across 260 respondents * Reconcile provider and demand estimates * Cross-check consultation unit economics * Stress-test specialty mix assumptions ### Phase 2: Market Size Estimation #### Top-Down Assessment * National telehealth-user penetration and healthcare utilization * Breakdown across primary, specialist and mental healthcare * Medicare and national digital-health operating indicators #### Bottom-Up Modeling * Provider-level virtual consultation volume benchmarks * Consultation pricing and reimbursement benchmarks * Visit volume multiplied by realized revenue #### Forecasting and Scenario Analysis * Patient penetration, visit frequency and service mix * Medicare policy and clinical-governance evolution * Baseline, optimistic, and constrained projections through 2032 ### Phase 3: Primary Research Coverage #### Scope Item / Segments Coverage spans the Australia Virtual Visits Market value chain from patient access and digital platforms through clinical delivery, payer integration and follow-up care. * Virtual-First Care Providers * General and Specialist Practices * Health Insurers and Employer Programs * Digital Health Infrastructure Providers #### Sample Size A total of 260 respondents were allocated across value-chain segments to provide balanced operating, clinical and commercial coverage of the Australia Virtual Visits Market. * Virtual-First Care Providers - 72 respondents (Medical Director, Telehealth Operations Manager) * General and Specialist Practices - 68 respondents (Practice Principal, Specialist Physician) * Health Insurers and Employer Programs - 56 respondents (Health Services Director, Benefits Manager) * Digital Health Infrastructure Providers - 64 respondents (Product Director, Clinical Informatics Lead) #### Validation and Triangulation Validation compares operational evidence across payer, provider, technology and patient-access cohorts before market assumptions are locked. * Cross-check provider volumes against patient utilization * Reconcile platform throughput with clinician capacity * Compare operational and strategic respondent estimates * Validate pricing against reimbursement and service mix --- ## Frequently Asked Questions # CHAPTER 12 - FAQs #### Q: How large is the Australia Virtual Visits Market in 2025? **A:** The Australia Virtual Visits Market was **worth USD 1,570 million in 2025**. The estimate uses a revenue lens covering synchronous clinician-to-patient telephone and video consultations delivered through Medicare-funded, private-pay, insurer-funded and institutional channels. The model triangulates patient usage, consultation volumes, provider economics and national Medicare telehealth evidence rather than treating broader remote monitoring or standalone software revenue as virtual visits. Post-pandemic utilization has normalized, but permanent Medicare access, private virtual clinics and persistent physical-care access gaps support the current revenue base. **Data used:** USD 1,570 million market value in 2025; 22.5% telehealth-user penetration in 2024-25. **So what:** Investors should evaluate monetization quality and recurring care pathways rather than interpreting the market as a pandemic-only demand spike. #### Q: What is the expected forecast for the Australia Virtual Visits Market? **A:** The market is forecast to reach **USD 2,907 million by 2032**, representing a **9.20% CAGR from 2025 to 2032**. Growth is expected to come from roughly 6.6% annual expansion in consultation volume plus increasing revenue per visit as higher-value mental-health, specialty, urgent-care and integrated digital pathways gain share. The forecast assumes permanent telehealth reimbursement remains broadly supportive and that operators comply with tighter clinical-governance standards. Growth therefore shifts from emergency adoption toward embedded care delivery and service-mix improvement. **Data used:** USD 2,907 million forecast value in 2032; 9.20% CAGR for 2025-2032. **So what:** The strongest investment cases are providers capable of expanding visit mix and retention without relying solely on rising primary-care volumes. #### Q: Where will the largest profit-pool shift occur in virtual visits? **A:** Profit pools are expected to migrate from commoditized low-complexity consultations toward specialty, mental-health, chronic-care and payer-integrated pathways. General practitioner consultations remain the largest volume pool, but specialist services support higher revenue per encounter and stronger clinical differentiation. Mental health is particularly attractive because 26.0% of people who accessed mental-health professionals in 2024-25 used telehealth at least once, while access delays remain substantial. Insurers and employer programs can further improve economics by reducing consumer acquisition costs and embedding repeat usage. **Data used:** 26.0% mental-health telehealth usage in 2024-25; 38.8% psychologist access delay or non-use when needed. **So what:** Providers should prioritize recurring, clinically differentiated pathways rather than compete exclusively on instant low-price GP access. #### Q: What is the principal risk to virtual-visit growth in Australia? **A:** The primary risk is the interaction between utilization normalization and stricter clinical governance. Overall telehealth penetration fell from 30.8% in 2021-22 to 22.5% in 2024-25, demonstrating that emergency-era demand cannot be extrapolated indefinitely. At the same time, AHPRA has tightened guidance around telehealth prescribing and low-touch consultation models. Providers must maintain clinically appropriate real-time assessment, escalation routes, privacy and continuity of care. These requirements increase operating complexity but favour scaled platforms that can invest in governance and practitioner quality. **Data used:** 30.8% penetration in 2021-22; 22.5% penetration in 2024-25. **So what:** Market entrants should treat clinical governance infrastructure as a core capability and competitive moat rather than a compliance afterthought. #### Q: How does Australia compare with other digitally mature virtual-care markets? **A:** Australia ranks third in the selected peer set behind the United Kingdom and Canada by modeled 2025 virtual-visit revenue, while remaining ahead of Singapore and New Zealand. Its competitive advantage is a nationally established Medicare telehealth framework combined with high patient willingness to reuse virtual care. Australia is forecast to grow faster than the more mature Canadian and UK markets but somewhat slower than smaller Singapore and New Zealand markets, where digital-primary-care systems still have greater room for penetration expansion. **Data used:** Australia peer ranking 3rd in 2025; Australia forecast CAGR 9.2% for 2025-2032. **So what:** Australia offers a balance of market scale and remaining digital-care whitespace that is attractive for regional virtual-care expansion strategies. #### Q: What is the strongest structural demand driver for future virtual visits? **A:** Persistent access friction in physical healthcare is the strongest demand driver. In 2024-25, 26.6% of Australians reported delaying or not seeing a GP when needed, while virtual-care reuse intent reached 90.3% among prior telehealth users. The combination creates a strong commercial foundation for after-hours access, regional care, mental-health pathways and rapid specialist follow-up. Permanent Medicare telehealth coverage reduces reimbursement friction, while electronic prescribing and digital referrals allow more consultations to be completed without forcing patients back into an offline administrative process. **Data used:** 26.6% GP access delay or non-use in 2024-25; 90.3% telehealth reuse intent. **So what:** Providers should position virtual care around measurable access problems and continuity outcomes rather than convenience alone. --- ## Table of Contents # Table of Contents ### Market Report Structure Comprehensive coverage across three strategic phases - Market Assessment, Go-To-Market Strategy, and Survey - delivering end-to-end insights from market analysis and execution roadmap to customer demand validation. ## Market Assessment Phase Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts. ### 1. Executive Summary and Approach ### 2. Australia Virtual Visits Market Overview #### 2.1 Key Insights and Strategic Recommendations #### 2.2 Australia Virtual Visits Market Overview #### 2.3 Definition and Scope #### 2.4 Evolution of Market Ecosystem #### 2.5 Timeline of Key Regulatory Milestones #### 2.6 Value Chain and Stakeholder Mapping #### 2.7 Business Cycle Analysis #### 2.8 Policy and Incentive Landscape ### 3. Australia Virtual Visits Market Analysis #### 3.1 Growth Drivers ##### 3.1.1 Permanent Medicare Reimbursement Infrastructure ##### 3.1.2 High Patient Acceptance and Persistent Access Gaps ##### 3.1.3 Digital Health Infrastructure Integration #### 3.2 Market Challenges ##### 3.2.1 Post-Pandemic Utilization Normalization ##### 3.2.2 Clinical Governance and Prescribing Constraints ##### 3.2.3 Digital and Socioeconomic Access Inequality #### 3.3 Market Opportunities ##### 3.3.1 Virtual Mental Health Expansion ##### 3.3.2 After-Hours and Regional Access ##### 3.3.3 Insurer and Consumer Virtual-Care Bundles #### 3.4 Market Trends ##### 3.4.1 Migration from Telephone to Integrated Virtual Workflows ##### 3.4.2 Growth of Virtual-First Condition-Specific Clinics ##### 3.4.3 Expansion of Insurer-Sponsored Virtual Care ##### 3.4.4 Clinician-Supervised AI Workflow Adoption #### 3.5 Government Regulation ##### 3.5.1 Permanent MBS Telehealth Arrangements ##### 3.5.2 AHPRA Virtual-Care Clinical Governance ##### 3.5.3 Telehealth Prescribing Standards ##### 3.5.4 Digital Privacy and Patient Record Requirements ### 4. SWOT Analysis ### 5. Stakeholder Analysis ### 6. Porter's Five Forces Analysis ### 7. Australia Virtual Visits Market Size #### 7.1 By Value #### 7.2 By Volume #### 7.3 By Average Revenue per Visit ### 8. Australia Virtual Visits Market Segmentation #### 8.1 Service Type ##### 8.1.1 General Practitioner Consultations ##### 8.1.2 Specialist Consultations ##### 8.1.3 Mental Health and Allied Health Consultations ##### 8.1.4 Urgent and After-Hours Virtual Care #### 8.2 Care Setting ##### 8.2.1 Primary Care Practices ##### 8.2.2 Specialist and Allied Health Clinics ##### 8.2.3 Hospital and Virtual Hospital Services ##### 8.2.4 Direct-to-Consumer Digital Clinics #### 8.3 End User ##### 8.3.1 Adults Aged 18-64 ##### 8.3.2 Older Adults Aged 65+ ##### 8.3.3 Children and Adolescents ##### 8.3.4 Rural and Remote Patients #### 8.4 Clinical Specialty ##### 8.4.1 General Medicine ##### 8.4.2 Mental Health ##### 8.4.3 Women's and Sexual Health ##### 8.4.4 Emergency and Acute Triage #### 8.5 Distribution Channel ##### 8.5.1 Scheduled Practice Telehealth ##### 8.5.2 On-Demand Digital Clinics ##### 8.5.3 Health Plan and Employer Channels ##### 8.5.4 Government and Hospital Channels #### 8.6 Technology ##### 8.6.1 Audio Consultation ##### 8.6.2 Video Consultation ##### 8.6.3 Integrated Digital Workflow ##### 8.6.4 AI-Assisted Virtual Care #### 8.7 Geography ##### 8.7.1 New South Wales ##### 8.7.2 Victoria ##### 8.7.3 Queensland ##### 8.7.4 Western and Southern Australia ### 9. Australia Virtual Visits Market Competitive Analysis #### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises) #### 9.2 Cross Comparison of Key Players ##### 9.2.1 Company Name ##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention) ##### 9.2.3 Virtual Consultation Volume ##### 9.2.4 Clinician Network Capacity ##### 9.2.5 Virtual Care Revenue Growth ##### 9.2.6 Contribution Margin per Consultation #### 9.3 SWOT Analysis of Top Players #### 9.4 Pricing Analysis #### 9.5 Detailed Profile of Major Companies ##### 9.5.1 Medibank / Amplar Health ##### 9.5.2 Eucalyptus ##### 9.5.3 Healthengine ##### 9.5.4 HotDoc ##### 9.5.5 Instant Consult ##### 9.5.6 GP2U Telehealth ##### 9.5.7 My Emergency Doctor ##### 9.5.8 Medmate ##### 9.5.9 Hola Health ##### 9.5.10 Updoc ### 10. Australia Virtual Visits Market End-User Analysis #### 10.1 Procurement Behavior of Key End-Users ##### 10.1.1 Patient Choice of Virtual versus In-Person Care ##### 10.1.2 Insurer Virtual-Care Procurement ##### 10.1.3 Employer Health Program Procurement ##### 10.1.4 Hospital Virtual-Service Procurement #### 10.2 Corporate Spend Patterns ##### 10.2.1 Per-Consultation Provider Fees ##### 10.2.2 Subscription and Membership Models ##### 10.2.3 Insurer-Funded Service Bundles ##### 10.2.4 Enterprise Virtual-Care Contracts #### 10.3 Pain Point Analysis by End-User Category ##### 10.3.1 GP Appointment Availability ##### 10.3.2 Specialist Access and Wait Times ##### 10.3.3 Mental Health Affordability ##### 10.3.4 Rural Travel and Access Burden #### 10.4 User Readiness for Adoption ##### 10.4.1 Telehealth Reuse Intent ##### 10.4.2 Video Consultation Readiness ##### 10.4.3 Digital Prescription Adoption ##### 10.4.4 Patient Record Connectivity #### 10.5 Post-Deployment ROI and Use Case Expansion ##### 10.5.1 Avoided Travel Costs ##### 10.5.2 Clinician Capacity Optimization ##### 10.5.3 Reduced Administrative Friction ##### 10.5.4 Specialty Care Expansion ### 11. Australia Virtual Visits Market Future Size #### 11.1 By Value #### 11.2 By Volume #### 11.3 By Average Revenue per Visit ## Go-To-Market Strategy Phase Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook. ### 1. Whitespace Analysis and Business Model Canvas #### 1.1 Rural and Regional Virtual Access #### 1.2 Mental Health Care Whitespace #### 1.3 After-Hours Primary Care #### 1.4 Insurer-Integrated Virtual Care ### 2. Marketing and Positioning Recommendations #### 2.1 Access-Led Patient Positioning #### 2.2 Clinically Governed Digital Care #### 2.3 Continuity and Follow-Up Positioning #### 2.4 Specialty Virtual-Care Differentiation ### 3. Distribution Plan #### 3.1 Direct-to-Consumer Digital Acquisition #### 3.2 Health Insurer Partnerships #### 3.3 GP Practice Integrations #### 3.4 Employer and Institutional Partnerships ### 4. Channel and Pricing Gaps #### 4.1 Private GP Consultation Pricing #### 4.2 Medicare-Eligible Care Pathways #### 4.3 Subscription Care Bundles #### 4.4 Specialist Virtual-Care Pricing ### 5. Unmet Demand and Latent Needs #### 5.1 After-Hours Care Access #### 5.2 Mental Health Appointment Availability #### 5.3 Regional Specialist Access #### 5.4 Chronic Follow-Up Convenience ### 6. Customer Relationship #### 6.1 Patient Retention Programs #### 6.2 Usual-GP Care Coordination #### 6.3 Digital Follow-Up Workflows #### 6.4 Health Plan Member Engagement ### 7. Value Proposition #### 7.1 Faster Healthcare Access #### 7.2 Lower Patient Travel Burden #### 7.3 Integrated Digital Care Completion #### 7.4 Clinically Governed Convenience ### 8. Key Activities #### 8.1 Clinician Network Development #### 8.2 Patient Acquisition Optimization #### 8.3 Clinical Governance Management #### 8.4 Digital Integration Development ### 9. Entry Strategy Evaluation #### 9.1 Domestic Market Entry Strategy ##### 9.1.1 Launch in High-Demand Metropolitan Corridors ##### 9.1.2 Build Regional Access Partnerships ##### 9.1.3 Secure Insurer and Employer Channels ##### 9.1.4 Expand into Specialty Care #### 9.2 Export Entry Strategy ##### 9.2.1 Adapt Australian Clinical Governance Model ##### 9.2.2 Prioritize Comparable English-Speaking Markets ##### 9.2.3 Localize Reimbursement Integrations ##### 9.2.4 Establish Local Practitioner Networks ### 10. Entry Mode Assessment #### 10.1 Organic Virtual Clinic Launch #### 10.2 Provider Partnership Model #### 10.3 Health Plan Joint Offering #### 10.4 Acquisition of Existing Platform ### 11. Capital and Timeline Estimation #### 11.1 Clinical Platform Investment #### 11.2 Practitioner Network Investment #### 11.3 Compliance and Governance Investment #### 11.4 Patient Acquisition Investment ### 12. Control vs Risk Trade-Off #### 12.1 Owned Clinician Network #### 12.2 Partner Clinician Network #### 12.3 Insurer Distribution Dependence #### 12.4 Medicare Exposure ### 13. Profitability Outlook #### 13.1 Consultation Revenue Economics #### 13.2 Patient Acquisition Efficiency #### 13.3 Clinician Utilization Leverage #### 13.4 Specialty Mix Improvement ### 14. Potential Partner List #### 14.1 Health Insurers #### 14.2 General Practice Networks #### 14.3 Digital Health Infrastructure Providers #### 14.4 Employer Health Programs ### 15. Execution Roadmap #### 15.1 Phased Plan for Market Entry ##### 15.1.1 Market Setup ##### 15.1.2 Market Entry ##### 15.1.3 Growth Acceleration ##### 15.1.4 Scale and Stabilize #### 15.2 Key Activities and Milestones ##### 15.2.1 Secure Clinical Governance Framework ##### 15.2.2 Recruit Practitioner Network ##### 15.2.3 Launch Priority Patient Pathways ##### 15.2.4 Scale Payer and Practice Partnerships ## Survey Phase Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers. ### 1. Research Design and Sample Architecture #### 1.1 Research Objectives and Scope #### 1.2 Sample Size Rationale and Representation #### 1.3 Customer Cohort Definitions #### 1.4 Geographic Coverage: Priority Metros and Tier 2/3 Cities ### 2. Data Collection Methodology #### 2.1 Structured Interview Framework (50 In-Depth Interviews) ##### 2.1.1 Interview Guide and Question Design ##### 2.1.2 Respondent Recruitment and Screening Criteria ##### 2.1.3 Interview Execution and Quality Control ##### 2.1.4 Qualitative Coding and Insight Extraction #### 2.2 Online Survey Design (200 Structured Surveys) ##### 2.2.1 Survey Instrument and Attribute Coverage ##### 2.2.2 Platform Selection and Distribution Channels ##### 2.2.3 Response Validation and Data Cleaning ##### 2.2.4 Statistical Significance and Margin of Error ### 3. Customer Cohort Profiles #### 3.1 Cohort 1: Frequent Primary-Care Users ##### 3.1.1 Cohort Definition and Size ##### 3.1.2 Key Demand Attributes ##### 3.1.3 Purchase Decision Drivers ##### 3.1.4 Represented Sample Size and Metro Distribution #### 3.2 Cohort 2: Mental Health and Specialist Users ##### 3.2.1 Cohort Definition and Size ##### 3.2.2 Key Demand Attributes ##### 3.2.3 Purchase Decision Drivers ##### 3.2.4 Represented Sample Size and City Distribution #### 3.3 Cohort 3: Rural and Remote Patients ##### 3.3.1 Cohort Definition and Size ##### 3.3.2 Key Demand Attributes ##### 3.3.3 Purchase Decision Drivers ##### 3.3.4 Represented Sample Size and Tier 2/3 City Distribution #### 3.4 Cohort 4: Insurer and Employer-Sponsored Users ##### 3.4.1 Cohort Definition and Size ##### 3.4.2 Key Demand Attributes ##### 3.4.3 Procurement and Compliance Drivers ##### 3.4.4 Represented Sample Size and Regional Distribution ### 4. Demand Attributes Analysis #### 4.1 Macroeconomic and Healthcare Access Influences on Demand ##### 4.1.1 Population and Healthcare Utilization Linkages ##### 4.1.2 GP Availability and Access Impact ##### 4.1.3 Household Cost Pressures and Consultation Timing ##### 4.1.4 Public and Private Funding Dependency #### 4.2 End-User Behavior and Consumption Patterns ##### 4.2.1 Frequency and Volume of Virtual Consultations ##### 4.2.2 After-Hours and Seasonal Demand Variations ##### 4.2.3 Usual-GP Loyalty vs Convenience Trade-Off ##### 4.2.4 Switching Triggers and Retention Factors #### 4.3 Pricing Perception and Value Assessment ##### 4.3.1 Willingness to Pay Across Cohorts ##### 4.3.2 Price Benchmarking Against In-Person Care ##### 4.3.3 Specialty Pricing Differences ##### 4.3.4 Total Access Cost Perception #### 4.4 Quality, Safety, and Compliance Expectations ##### 4.4.1 Practitioner Registration Requirements ##### 4.4.2 Clinical Safety and Prescribing Expectations ##### 4.4.3 Perception of Virtual-First vs Hybrid Providers ##### 4.4.4 Follow-Up and Care Coordination Expectations #### 4.5 Cultural, Regional, and Contextual Demand Factors ##### 4.5.1 Metropolitan and Regional Demand Hotspots ##### 4.5.2 Patient Preference for Existing Care Relationships ##### 4.5.3 Family and Practitioner Influence ##### 4.5.4 Digital Adoption and Health Literacy #### 4.6 Marketing, Awareness, and Channel Influence ##### 4.6.1 Health Insurer Member Communications ##### 4.6.2 Role of Digital Search and Platforms ##### 4.6.3 GP Practice Referral Influence ##### 4.6.4 Employer Health Program Influence ### 5. Unmet Needs and Latent Demand Signals #### 5.1 Identified Gaps Between Current Supply and User Expectations #### 5.2 Latent Demand in Underpenetrated Patient Segments #### 5.3 Willingness to Adopt New Virtual-Care Formats #### 5.4 Pain Points Surfaced Across Cohorts ### 6. Key Findings and Strategic Implications #### 6.1 Top Demand Drivers Ranked by Cohort #### 6.2 Barriers to Purchase and Adoption #### 6.3 High-Priority Customer Segments for Market Entry #### 6.4 Recommendations for Service, Pricing, and Channel Strategy ### Disclaimer ### Contact Us